Key statistics
On Wednesday, Calliditas Therapeutics AB (CALT:NSQ) closed at 40.03, -4.92% below its 52-week high of 42.10, set on Sep 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 40.46 |
---|---|
High | 40.80 |
Low | 39.20 |
Bid | 19.95 |
Offer | 59.85 |
Previous close | 39.99 |
Average volume | 7.01k |
---|---|
Shares outstanding | 29.97m |
Free float | 24.97m |
P/E (TTM) | -- |
Market cap | 1.22bn USD |
EPS (TTM) | -1.76 USD |
Data delayed at least 15 minutes, as of Sep 18 2024 20:58 BST.
More ▼
Press releases
- Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
- Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)
- Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei
- Calliditas Interim Report January to June 2024
- Invitation to the presentation of Calliditas´s interim report January - June 2024
- Number of shares and votes in Calliditas Therapeutics
- Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy
- Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis
- Launch of Phase 3 clinical trial with Nefecon in Japan
More ▼